SC 13D Filing

Company

GYRE THERAPEUTICS, INC.

Filed

July 24, 2019

Accession Number

0000898432-19-001014

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →